Julie A. Vetalice, Author at ORTHOWORLD

Study Results: OrthoTrophix TPX-100 in Knee OA

OrthoTrophix announced results of the first proof of principle study of TPX-100 in bilateral knee osteoarthritis, showing improvements at 6 and 12 months in key knee-related outcome measures.

Dec 15, 2016

SpinalCyte’s IRB Approval for Phase I Clinical Trial

Orthobiologics ORTHOFLASH

SpinalCyte received IRB approval to commence Phase I clinical trials with its CybroCell dermal fibroblast cell product in the treatment of degenerative disc disease.

Dec 15, 2016

aap Implantate’s New U.S. Distribution Contract for LOQTEQ Products

Company Updates Competitive Landscape

aap Implantate entered into a distribution contract for LOQTEQ® trauma products with an unnamed U.S. healthcare service provider.

Dec 15, 2016

U.K. National Joint Registry Analysis of Zimmer Biomet Trabecular Metal Cups

Joint Replacement ORTHOFLASH

Zimmer Biomet announced positive outcomes associated with use of Trabecular Metal™ Cups in >9,500 revision hip arthroplasty cases, as reported in data from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man.

Dec 15, 2016

Zimmer Biomet Updates: Product Supply Matters, Form 483

Company Updates Competitive Landscape

Zimmer Biomet reports that most product lines impacted by previously-disclosed shipping delays have returned to full shipping capacity, and disclosed the receipt of a Form 483 following an FDA inspection of a legacy Biomet manufacturing site in Warsaw, Indiana.

Dec 14, 2016

Zimmer Biomet Launches PrimaGen Advanced Allograft

Orthobiologics ORTHOFLASH

Zimmer Biomet launched PrimaGen Advanced™ Allograft, an autograft substitute comprising cancellous bone + demineralized cortical bone fibers with verified osteoinductivity.

Dec 14, 2016

FDA Approves Vericel’s MACI for Treatment of Adult Symptomatic Knee Cartilage Defects

Orthobiologics ORTHOFLASH

FDA approved Vericel’s MACI® for the repair of adult symptomatic single or multiple full-thickness cartilage defects of the knee.

Dec 14, 2016

New DUROLANE Agreement

Company Updates Competitive Landscape

Bioventus entered into an agreement with Galderma to bring DUROLANE knee osteoarthritis treatment to the U.S.

Dec 14, 2016

12-month Clinical and Radiographic Results with SImmetry Sacroiliac Joint Fusion

ORTHOFLASH Spine

Results from a study of Zyga Technology’s SImmetry® Sacroiliac Joint Fusion procedure indicate that, at 12 months, fusion was reported in 88% of patients and back pain decreased by 46%.

Dec 14, 2016

Jury Finds in Favor of Arthrex vs. Smith & Nephew

ORTHOFLASH Sports Medicine

Arthrex was granted US $17MM+ in damages following a jury finding of willful infringement by Smith & Nephew/ArthroCare on two Arthrex patents relative to knotless and cross-support technology.

Dec 13, 2016

Get the ORTHOWORLD Newsletter!

Contact Us